Substantia Nigra Volumetry with 3-T MRI in De Novo and Advanced Parkinson Disease

Paolo Vitali1, Marina I Pan1, Fulvia Palesi1

  • 1From the Department of Neuroradiology, Brain MRI 3T Research Center (P.V., G.G., A.F., C.A.M.G.W.), Brain Connectivity Centre (F.P.), and Parkinson's Disease and Movement Disorders Unit (B.M., R.Z., C.P.), IRCCS Mondino Foundation, Pavia, Italy; Departments of Neurology (M.I.P.) and Brain and Behavioural Sciences (F.P., C.A.M.G.W.), University of Pavia, Pavia, Italy; Neuroradiology Unit, San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy (N.A.); Department of Radiology, Acqui Terme Hospital, Acqui Terme, Italy (P.F.); and NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, England (C.A.M.G.W.).

Radiology
|June 17, 2020
PubMed